Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
1998 4
1999 1
2000 1
2002 1
2003 7
2004 2
2005 5
2006 2
2007 2
2008 4
2009 3
2010 1
2011 2
2012 8
2013 4
2014 11
2015 10
2016 6
2017 6
2018 9
2019 6
2020 2
2021 5
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Results by year
Filters applied: . Clear all
Page 1
Practical management of suspected hypersensitivity reactions to anti-tuberculosis drugs.
Bermingham WH, Bhogal R, Arudi Nagarajan S, Mutlu L, El-Shabrawy RM, Madhan R, Krishnaswamy UM, Murali MR, Kudagammana ST, Shrestha R, Sumantri S, Christopher DJ, Mahesh PA, Dedicoat M, Krishna MT. Bermingham WH, et al. Among authors: dedicoat m. Clin Exp Allergy. 2022 Mar;52(3):375-386. doi: 10.1111/cea.14084. Epub 2022 Jan 20. Clin Exp Allergy. 2022. PMID: 34939251 Review.
Tuberculosis transmission.
Munang ML, Dedicoat M. Munang ML, et al. Among authors: dedicoat m. J Am Dent Assoc. 2014 Aug;145(8):800-1. doi: 10.1016/s0002-8177(14)60184-7. J Am Dent Assoc. 2014. PMID: 25082928 No abstract available.
Where next with for vitamin D and tuberculosis?
Dedicoat M. Dedicoat M. Int J Tuberc Lung Dis. 2020 Mar 1;24(3):265. doi: 10.5588/ijtld.20.0045. Int J Tuberc Lung Dis. 2020. PMID: 32228752 No abstract available.
Management of patients with multidrug-resistant tuberculosis.
Lange C, Aarnoutse RE, Alffenaar JWC, Bothamley G, Brinkmann F, Costa J, Chesov D, van Crevel R, Dedicoat M, Dominguez J, Duarte R, Grobbel HP, Günther G, Guglielmetti L, Heyckendorf J, Kay AW, Kirakosyan O, Kirk O, Koczulla RA, Kudriashov GG, Kuksa L, van Leth F, Magis-Escurra C, Mandalakas AM, Molina-Moya B, Peloquin CA, Reimann M, Rumetshofer R, Schaaf HS, Schön T, Tiberi S, Valda J, Yablonskii PK, Dheda K. Lange C, et al. Among authors: dedicoat m. Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622. Int J Tuberc Lung Dis. 2019. PMID: 31315696 Review.
Clinical standards for drug-susceptible pulmonary TB.
Akkerman OW, Duarte R, Tiberi S, Schaaf HS, Lange C, Alffenaar JWC, Denholm J, Carvalho ACC, Bolhuis MS, Borisov S, Bruchfeld J, Cabibbe AM, Caminero JA, Carvalho I, Chakaya J, Centis R, Dalcomo MP, D Ambrosio L, Dedicoat M, Dheda K, Dooley KE, Furin J, García-García JM, van Hest NAH, de Jong BC, Kurhasani X, Märtson AG, Mpagama S, Torrico MM, Nunes E, Ong CWM, Palmero DJ, Ruslami R, Saktiawati AMI, Semuto C, Silva DR, Singla R, Solovic I, Srivastava S, de Steenwinkel JEM, Story A, Sturkenboom MGG, Tadolini M, Udwadia ZF, Verhage AR, Zellweger JP, Migliori GB. Akkerman OW, et al. Among authors: dedicoat m. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):592-604. doi: 10.5588/ijtld.22.0228. Int J Tuberc Lung Dis. 2022. PMID: 35768923 Free PMC article.
The treatment of Legionnaires' disease.
Dedicoat M, Venkatesan P. Dedicoat M, et al. J Antimicrob Chemother. 1999 Jun;43(6):747-52. doi: 10.1093/jac/43.6.747. J Antimicrob Chemother. 1999. PMID: 10404312 Review. No abstract available.
101 results